Garnette D. Draper

Array ( [id] => 3862892 [patent_doc_number] => 05837293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity' [patent_app_type] => 1 [patent_app_number] => 8/481560 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 113 [patent_no_of_words] => 39726 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837293.pdf [firstpage_image] =>[orig_patent_app_number] => 481560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490569 [patent_doc_number] => 06417158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF' [patent_app_type] => B1 [patent_app_number] => 08/477638 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 22997 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417158.pdf [firstpage_image] =>[orig_patent_app_number] => 08477638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407984 [patent_doc_number] => 06271346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'TNF Receptors, TNF binding proteins and DNAs coding for them' [patent_app_type] => 1 [patent_app_number] => 8/484312 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 24712 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271346.pdf [firstpage_image] =>[orig_patent_app_number] => 484312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942922 [patent_doc_number] => 05981701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Tumor necrosis factor inhibitory protein and its purification' [patent_app_type] => 1 [patent_app_number] => 8/474691 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8765 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981701.pdf [firstpage_image] =>[orig_patent_app_number] => 474691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821365 [patent_doc_number] => 05783181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins' [patent_app_type] => 1 [patent_app_number] => 8/470299 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10315 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783181.pdf [firstpage_image] =>[orig_patent_app_number] => 470299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850366 [patent_doc_number] => 05767065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4' [patent_app_type] => 1 [patent_app_number] => 8/466324 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 24999 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767065.pdf [firstpage_image] =>[orig_patent_app_number] => 466324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083398 [patent_doc_number] => 06025154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Polynucleotides encoding human G-protein chemokine receptor HDGNR10' [patent_app_type] => 1 [patent_app_number] => 8/466343 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 14871 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025154.pdf [firstpage_image] =>[orig_patent_app_number] => 466343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933338 [patent_doc_number] => 05871723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'CXC chemokines as regulators of angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/468819 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 17 [patent_no_of_words] => 53553 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871723.pdf [firstpage_image] =>[orig_patent_app_number] => 468819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045725 [patent_doc_number] => 05874561 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'DNA, host cell and vector encoding a protein with cytokine inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 8/471227 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13753 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874561.pdf [firstpage_image] =>[orig_patent_app_number] => 471227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985135 [patent_doc_number] => 05861485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Polypeptides involved in body weight disorders, including obesity' [patent_app_type] => 1 [patent_app_number] => 8/470868 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 35259 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861485.pdf [firstpage_image] =>[orig_patent_app_number] => 470868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722921 [patent_doc_number] => 05702698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Methods of use of IL-1.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/461733 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 10819 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702698.pdf [firstpage_image] =>[orig_patent_app_number] => 461733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876397 [patent_doc_number] => 05747444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method of treating graft-versus-host disease' [patent_app_type] => 1 [patent_app_number] => 8/459811 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10232 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747444.pdf [firstpage_image] =>[orig_patent_app_number] => 459811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784146 [patent_doc_number] => 05840496 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method for diagnosing endometrial cancer' [patent_app_type] => 1 [patent_app_number] => 8/459814 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10239 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840496.pdf [firstpage_image] =>[orig_patent_app_number] => 459814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859625 [patent_doc_number] => 05795734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'EPH receptor ligands, and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/455001 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 41853 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795734.pdf [firstpage_image] =>[orig_patent_app_number] => 455001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881607 [patent_doc_number] => 05723119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Method for enhancing wound healing/repair with IL-4' [patent_app_type] => 1 [patent_app_number] => 8/451112 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10626 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723119.pdf [firstpage_image] =>[orig_patent_app_number] => 451112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4313811 [patent_doc_number] => 06248319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/449653 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 118 [patent_figures_cnt] => 108 [patent_no_of_words] => 69099 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248319.pdf [firstpage_image] =>[orig_patent_app_number] => 449653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011020 [patent_doc_number] => 05889156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'TNF deletion muteins' [patent_app_type] => 1 [patent_app_number] => 8/449689 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 17696 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889156.pdf [firstpage_image] =>[orig_patent_app_number] => 449689 [rel_patent_id] =>[rel_patent_doc_number] =>)